Concepedia

Alexander Bär

AB

Statistics

Publications

4

Citations

69

H-Index

4

Active since

2018

Affiliations

University of Bayreuth(Current)

Alexander Bär is an author at University of Bayreuth specializing in pharmacology, ligand binding, and medicine.

Publications per year

2018–2023

4

Publications

4

<i>N</i>,<i>N</i>-Dialkylbenzimidazol-2-ylidene platinum complexes – effects of alkyl residues and ancillary<i>cis</i>-ligands on anticancer activity

Tobias Rehm, Matthias Rothemund, Alexander Bär et al. · Dalton Transactions · 2018 · 25 citations

Medicine, Medicinal Chemistry, Pharmacology +13

High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro

Sasha Soldati, Alexander Bär, Mykhailo Vladymyrov et al. · Journal of Neuroinflammation · 2023 · 18 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Guided Antitumoural Drugs: (Imidazol‐2‐ylidene)(L)gold(I) Complexes Seeking Cellular Targets Controlled by the Nature of Ligand L

Sofia I. Bär, Madeleine Gold, Sebastian W. Schleser et al. · Chemistry - A European Journal · 2020 · 14 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Inhibition of Type IV Secretion Activity and Growth of Helicobacter pylori by Cisplatin and Other Platinum Complexes

Clara Lettl, Franziska Schindele, Giambattista Testolin et al. · Frontiers in Cellular and Infection Microbiology · 2020 · 12 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–4 of 4